Ken Griffin's position in Krystal Biotech is currently worth $1.28 Million. That's 0.00% of their equity portfolio (2584th largest holding). The first Krystal Biotech trade was made in Q4 2018. Since then Ken Griffin bought shares ten more times and sold shares on eight occasions. The stake costed the investor $635 Thousand, netting the investor a gain of 101% so far.